Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

The effect of amino acid substitution at position 88 on the structure and stability of transthyretin.

Yokoyama T, Hanawa Y, Obita T, Mizuguchi M.

Amyloid. 2019;26(sup1):43-44. doi: 10.1080/13506129.2019.1582507. No abstract available.

PMID:
31343290
2.

Crystallization and Biophysical Approaches for Studying the Interactions Between the Vps4-MIT Domain and ESCRT-III Proteins.

Obita T, Kojima R, Mizuguchi M.

Methods Mol Biol. 2019;1998:175-187. doi: 10.1007/978-1-4939-9492-2_13.

PMID:
31250302
3.

Design, synthesis, and evaluation of novel inhibitors for wild-type human serine racemase.

Takahara S, Nakagawa K, Uchiyama T, Yoshida T, Matsumoto K, Kawasumi Y, Mizuguchi M, Obita T, Watanabe Y, Hayakawa D, Gouda H, Mori H, Toyooka N.

Bioorg Med Chem Lett. 2018 Feb 1;28(3):441-445. doi: 10.1016/j.bmcl.2017.12.021. Epub 2017 Dec 13.

PMID:
29277459
4.

Characterization of susceptibility variants of poliovirus grown in the presence of favipiravir.

Daikoku T, Mizuguchi M, Obita T, Yokoyama T, Yoshida Y, Takemoto M, Shiraki K.

J Microbiol Immunol Infect. 2018 Oct;51(5):581-586. doi: 10.1016/j.jmii.2017.03.004. Epub 2017 Jun 29.

5.

Stability and crystal structures of His88 mutant human transthyretins.

Yokoyama T, Hanawa Y, Obita T, Mizuguchi M.

FEBS Lett. 2017 Jul;591(13):1862-1871. doi: 10.1002/1873-3468.12704. Epub 2017 Jun 20.

6.

A novel serine racemase inhibitor suppresses neuronal over-activation in vivo.

Mori H, Wada R, Takahara S, Horino Y, Izumi H, Ishimoto T, Yoshida T, Mizuguchi M, Obita T, Gouda H, Hirono S, Toyooka N.

Bioorg Med Chem. 2017 Jul 15;25(14):3736-3745. doi: 10.1016/j.bmc.2017.05.011. Epub 2017 May 11.

PMID:
28533113
7.

Crystal Structure of Human General Transcription Factor TFIIE at Atomic Resolution.

Miwa K, Kojima R, Obita T, Ohkuma Y, Tamura Y, Mizuguchi M.

J Mol Biol. 2016 Oct 23;428(21):4258-4266. doi: 10.1016/j.jmb.2016.09.008. Epub 2016 Sep 15.

PMID:
27639436
8.

Allosteric modulation of the binding affinity between PQBP1 and the spliceosomal protein U5-15kD.

Mizuguchi M, Obita T, Kajiyama A, Kozakai Y, Nakai T, Nabeshima Y, Okazawa H.

FEBS Lett. 2016 Jul;590(14):2221-31. doi: 10.1002/1873-3468.12256. Epub 2016 Jun 28.

9.

Structural Fine-Tuning of MIT-Interacting Motif 2 (MIM2) and Allosteric Regulation of ESCRT-III by Vps4 in Yeast.

Kojima R, Obita T, Onoue K, Mizuguchi M.

J Mol Biol. 2016 Jun 5;428(11):2392-2404. doi: 10.1016/j.jmb.2016.04.007. Epub 2016 Apr 10.

PMID:
27075672
10.

Characterization of the interaction between Trypanosoma brucei Pex5p and its receptor Pex14p.

Watanabe Y, Kawaguchi K, Okuyama N, Sugawara Y, Obita T, Mizuguchi M, Morita M, Imanaka T.

FEBS Lett. 2016 Jan;590(2):242-50. doi: 10.1002/1873-3468.12044. Epub 2016 Jan 5.

11.

In silico and pharmacological screenings identify novel serine racemase inhibitors.

Mori H, Wada R, Li J, Ishimoto T, Mizuguchi M, Obita T, Gouda H, Hirono S, Toyooka N.

Bioorg Med Chem Lett. 2014 Aug 15;24(16):3732-5. doi: 10.1016/j.bmcl.2014.07.003. Epub 2014 Jul 5.

PMID:
25066953
12.

Transient α-helices in the disordered RPEL motifs of the serum response factor coactivator MKL1.

Mizuguchi M, Fuju T, Obita T, Ishikawa M, Tsuda M, Tabuchi A.

Sci Rep. 2014 Jun 9;4:5224. doi: 10.1038/srep05224.

13.

Mutations in the PQBP1 gene prevent its interaction with the spliceosomal protein U5-15 kD.

Mizuguchi M, Obita T, Serita T, Kojima R, Nabeshima Y, Okazawa H.

Nat Commun. 2014 Apr 30;5:3822. doi: 10.1038/ncomms4822.

PMID:
24781215
14.

[A role for crenarchaeal ESCRT system in cell division].

Obita T.

Seikagaku. 2014 Feb;86(1):59-62. Review. Japanese. No abstract available.

PMID:
24693699
15.

ESCRT-III binding protein MITD1 is involved in cytokinesis and has an unanticipated PLD fold that binds membranes.

Hadders MA, Agromayor M, Obita T, Perisic O, Caballe A, Kloc M, Lamers MH, Williams RL, Martin-Serrano J.

Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17424-9. doi: 10.1073/pnas.1206839109. Epub 2012 Oct 8.

16.

Molecular and structural basis of ESCRT-III recruitment to membranes during archaeal cell division.

Samson RY, Obita T, Hodgson B, Shaw MK, Chong PL, Williams RL, Bell SD.

Mol Cell. 2011 Jan 21;41(2):186-96. doi: 10.1016/j.molcel.2010.12.018.

17.

Evolution and assembly of ESCRTs.

Ghazi-Tabatabai S, Obita T, Pobbati AV, Perisic O, Samson RY, Bell SD, Williams RL.

Biochem Soc Trans. 2009 Feb;37(Pt 1):151-5. doi: 10.1042/BST0370151.

PMID:
19143621
18.

[Roles of ESCRT complexes in the MVB pathway].

Obita T, Perisic O, Williams RL.

Tanpakushitsu Kakusan Koso. 2008 Dec;53(16 Suppl):2089-93. Review. Japanese. No abstract available.

PMID:
21038590
19.

A role for the ESCRT system in cell division in archaea.

Samson RY, Obita T, Freund SM, Williams RL, Bell SD.

Science. 2008 Dec 12;322(5908):1710-3. doi: 10.1126/science.1165322. Epub 2008 Nov 13.

20.

Complete covalent structure of nisin Q, new natural nisin variant, containing post-translationally modified amino acids.

Fukao M, Obita T, Yoneyama F, Kohda D, Zendo T, Nakayama J, Sonomoto K.

Biosci Biotechnol Biochem. 2008 Jul;72(7):1750-5. Epub 2008 Jul 7.

21.

Structure-guided identification of a new catalytic motif of oligosaccharyltransferase.

Igura M, Maita N, Kamishikiryo J, Yamada M, Obita T, Maenaka K, Kohda D.

EMBO J. 2008 Jan 9;27(1):234-43. Epub 2007 Nov 29.

22.

Tom20 recognizes mitochondrial presequences through dynamic equilibrium among multiple bound states.

Saitoh T, Igura M, Obita T, Ose T, Kojima R, Maenaka K, Endo T, Kohda D.

EMBO J. 2007 Nov 14;26(22):4777-87. Epub 2007 Oct 18.

23.

Structural basis for selective recognition of ESCRT-III by the AAA ATPase Vps4.

Obita T, Saksena S, Ghazi-Tabatabai S, Gill DJ, Perisic O, Emr SD, Williams RL.

Nature. 2007 Oct 11;449(7163):735-9.

PMID:
17928861
24.

Purification, crystallization and preliminary X-ray diffraction studies of the soluble domain of the oligosaccharyltransferase STT3 subunit from the thermophilic archaeon Pyrococcus furiosus.

Igura M, Maita N, Obita T, Kamishikiryo J, Maenaka K, Kohda D.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Sep 1;63(Pt 9):798-801. Epub 2007 Aug 31.

25.

Crystallization and preliminary X-ray analysis of mitochondrial presequence receptor Tom20 in complexes with a presequence from aldehyde dehydrogenase.

Igura M, Ose T, Obita T, Sato C, Maenaka K, Endo T, Kohda D.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 May 1;61(Pt 5):514-7. Epub 2005 Apr 22.

26.

Identification of the region in Escherichia coli DnaA protein required for specific recognition of the DnaA box.

Yoshida Y, Obita T, Kokusho Y, Ohmura T, Katayama T, Ueda T, Imoto T.

Cell Mol Life Sci. 2003 Sep;60(9):1998-2008.

PMID:
14523560
27.
28.

Solution structure and activity of mouse lysozyme M.

Obita T, Ueda T, Imoto T.

Cell Mol Life Sci. 2003 Jan;60(1):176-84.

PMID:
12613666
29.

Determination of the secondary structure in solution of the Escherichia coli DnaA DNA-binding domain.

Obita T, Iwura T, Su'etsugu M, Yoshida Y, Tanaka Y, Katayama T, Ueda T, Imoto T.

Biochem Biophys Res Commun. 2002 Nov 22;299(1):42-8.

PMID:
12435387
30.

Flocculation properties of pectin in various suspensions.

Yokoi H, Obita T, Hirose J, Hayashi S, Takasaki Y.

Bioresour Technol. 2002 Sep;84(3):287-90.

PMID:
12118708
31.

NMR identification of the Tom20 binding segment in mitochondrial presequences.

Muto T, Obita T, Abe Y, Shodai T, Endo T, Kohda D.

J Mol Biol. 2001 Feb 16;306(2):137-43.

PMID:
11237589
32.

Assignment of 1H and 15N resonances of mouse lysozyme M.

Obita T, Ueda T, Tanaka Y, Hashimoto Y, Imoto T.

J Biomol NMR. 2000 Dec;18(4):361-2. No abstract available.

PMID:
11200531

Supplemental Content

Support Center